Parikh, SR; Campbell, H; Mandal, S; Ramsay, ME; Ladhani, SN
(2019)
Primary meningococcal conjunctivitis: Summary of evidence for the clinical and public health management of cases and close contacts.
J Infect, 79 (6).
pp. 490-494.
ISSN 1532-2742
https://doi.org/10.1016/j.jinf.2019.10.015
SGUL Authors: Ladhani, Shamez Nizarali
![]() |
Microsoft Word (.docx)
Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (78kB) |
Abstract
BACKGROUND: Neisseria meningitidis is a rare cause of acute bacterial conjunctivitis but can progress to invasive meningococcal disease (IMD) in the case and their close contacts. There is, however, a lack of consensus on the clinical and public health management of primary meningococcal conjunctivitis (PMC). METHODS: We searched Ovid MEDLINE via PubMed, EMBASE and NHS evidence (up to June 2019) for all publications relating to meningococcal conjunctivitis to provide an evidence-base for developing guidelines for the management of PMC cases and their close contacts. RESULTS: The review identified a 10-29% risk of IMD among PMC cases within two days of onset of eye infection (range: 3 h to 4 days). In one study, the risk of IMD in PMC cases treated with systemic antibiotics was 19 times lower than topical antibiotics alone (p = 0.001). IMD among close contacts of PMC cases is uncommon but potentially fatal. Whether meningococcal vaccination for PMC cases or close contacts provides any additional benefit is unclear. CONCLUSIONS: Systemic antibiotic treatment significantly reduces the risk of invasive disease in PMC cases, while antibiotic chemoprophylaxis for close contacts will reduce their risk of secondary IMD. These findings need to be highlighted in relevant clinical and public health guidelines.
Item Type: | Article | ||||||||
---|---|---|---|---|---|---|---|---|---|
Additional Information: | © 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | ||||||||
Keywords: | Chemoprophylaxis, Invasive meningococcal disease, Primary meningococcal conjunctivitis, Primary meningococcal conjunctivitis, Chemoprophylaxis, Invasive meningococcal disease, Microbiology, 1103 Clinical Sciences | ||||||||
SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) | ||||||||
Journal or Publication Title: | J Infect | ||||||||
ISSN: | 1532-2742 | ||||||||
Language: | eng | ||||||||
Dates: |
|
||||||||
Publisher License: | Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0 | ||||||||
PubMed ID: | 31669376 | ||||||||
Web of Science ID: | WOS:000500934300002 | ||||||||
Go to PubMed abstract | |||||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/111570 | ||||||||
Publisher's version: | https://doi.org/10.1016/j.jinf.2019.10.015 |
Statistics
Actions (login required)
![]() |
Edit Item |